Cargando…
Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives
Treatment-resistant schizophrenia (TRS) often results in severe disability and functional impairment. Currently, the diagnosis of TRS is largely exclusionary and emphasizes the improvement of symptoms that may not be detected early and treated according to TRS guideline. As the gold standard, clozap...
Autores principales: | Jiao, Shimeng, Cao, Ting, Cai, Hualin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597880/ https://www.ncbi.nlm.nih.gov/pubmed/36313375 http://dx.doi.org/10.3389/fphar.2022.1005702 |
Ejemplares similares
-
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
por: Vita, Antonio, et al.
Publicado: (2019) -
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches
por: Pisanu, Claudia, et al.
Publicado: (2019) -
Establishment of an assistive diagnostic model for schizophrenia with oxidative stress biomarkers
por: Wang, Shuying, et al.
Publicado: (2023) -
The role of inflammation in schizophrenia
por: Müller, Norbert, et al.
Publicado: (2015) -
Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs
por: Li, Nana, et al.
Publicado: (2020)